CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Sustained Efficacy and Comparable Safety and Immunogenicity after Transition to SB5 (an Adalimumab Biosimilar) Vs. Continuation of SB5 or Reference Adalimumab (Humira®) in Patients with Rheumatoid Arthritis: Results of Phase III Study
Author
Baranauskaite A.
Cheong SY.
+12 more
Dokoupilova E.
Ghil J.
Jaworski J.
Jedrychowicz-Rosiak K.
Niebrzydowski J.
Pileckyte M.
Racewicz A.
Sitek-Ziolkowska K.
Weinblat M.
Zhdan V.
Zielinska A.
Ждан Вячеслав Миколайович
Publication venue
American College of Rheumatology
Publication date
13/11/2016
Field of study
Get PDF
Electronic Archive of the Ukrainian Medical Stomatological Academy